Retracted: MicroRNA-520g induces epithelial–mesenchymal transition and promotes metastasis of hepatocellular carcinoma by targeting SMAD7 (FEBS Letters, (2015), 589, 1, (102-109), 10.1016/j.febslet.2014.11.031);MicroRNA-520g induces epithelial-mesenchymal transition and promotes metastasis of hepatocellular carcinoma by targeting SMAD7

FEBS Letters

Volumn 589, Issue 1, 2015, Pages 102-109

  Kan, Heping ^a   Guo, Wenbin ^b   Huang, Yuqi ^a   Liu, Dingli ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

^b THE THIRD AFFILIATED HOSPITAL OF SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

Abbreviations; EMT epithelial mesenchymal transition; ER estrogen receptor PR progesterone receptor; HCC hepatocellular carcinoma; SMAD family member 7; SMAD7

Indexed keywords

MICRORNA; MICRORNA 520G; SMAD7 PROTEIN; UNCLASSIFIED DRUG; MIRN520 MICRORNA, HUMAN; RNA; SMAD7 PROTEIN, HUMAN; TUMOR PROTEIN;

ADULT; ARTICLE; CANCER INFILTRATION; CANCER PROGNOSIS; CANCER STAGING; CELL INVASION; CELL MIGRATION; CELL MOTILITY; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DOWN REGULATION; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; GENE EXPRESSION; HEPATOCELLULAR CARCINOMA CELL LINE; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; LIVER CELL CARCINOMA; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; METASTASIS; OVERALL SURVIVAL; TUMOR INVASION; TUMOR RECURRENCE; UPREGULATION; AGED; CLINICAL TRIAL; GENETICS; HEPG2 CELL LINE; LIVER TUMOR; METABOLISM; MIDDLE AGED; MORTALITY; PATHOLOGY; SURVIVAL RATE;

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; DISEASE-FREE SURVIVAL; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; HEP G2 CELLS; HUMANS; LIVER NEOPLASMS; MALE; MICRORNAS; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM PROTEINS; RNA, NEOPLASM; SMAD7 PROTEIN; SURVIVAL RATE;

EID: 84918782427     PISSN: 00145793     EISSN: 18733468     Source Type: Journal    
DOI: 10.1002/1873-3468.14235     Document Type: Erratum

References (25)

1. R. Garzon, G.A. Calin, and C.M. Croce MicroRNAs in cancer Annu. Rev. Med. 60 2009 167 179
2. A. Rosa, and A.H. Brivanlou MicroRNAs in early vertebrate development Cell Cycle 8 2009 3513 3520
3. B.D. Harfe MicroRNAs in vertebrate development Curr. Opin. Genet. Dev. 15 2005 410 415
4. S. Vasudevan, Y. Tong, and J.A. Steitz Switching from repression to activation: microRNAs can up-regulate translation Science 318 2007 1931 1934
5. C.M. Croce, and G.A. Calin MiRNAs, cancer, and stem cell division Cell 122 2005 6 7
6. J. Lu, G. Getz, E.A. Miska, E. Alvarez-Saavedra, J. Lamb, D. Peck, A. Sweet-Cordero, B.L. Ebert, R.H. Mak, and A.A. Ferrando MicroRNA expression profiles classify human cancers Nature 435 2005 834 838
7. G.A. Calin, and C.M. Croce MicroRNA signatures in human cancers Nat. Rev. Cancer 6 2006 857 866
8. M.D. Jansson, and A.H. Lund MicroRNA and cancer Mol. Oncol. 6 2012 590 610
9. A.J. Lowery, N. Miller, A. Devaney, R.E. McNeill, P.A. Davoren, C. Lemetre, V. Benes, S. Schmidt, J. Blake, G. Ball, and M.J. Kerin MicroRNA signatures predict oestrogen receptor, progesterone receptor and HER2/neu receptor status in breast cancer Breast Cancer Res. 11 2009 R27
10. E. D'Asti, D. Garnier, T.H. Lee, L. Montermini, B. Meehan, and J. Rak Oncogenic extracellular vesicles in brain tumor progression Front. Physiol. 3 2012 294
11. M. Li, K.F. Lee, Y. Lu, I. Clarke, D. Shih, C. Eberhart, V.P. Collins, T. Van Meter, D. Picard, and L. Zhou Frequent amplification of a chr19q13.41 microRNA polycistron in aggressive primitive neuroectodermal brain tumors Cancer Cell 16 2009 533 546
12. W. Wang, L.J. Zhao, Y.X. Tan, H. Ren, and Z.T. Qi Identification of deregulated miRNAs and their targets in hepatitis B virus-associated hepatocellular carcinoma World J. Gastroenterol. 18 2012 5442 5453
13. W. Wang, L.J. Zhao, Y.X. Tan, H. Ren, and Z.T. Qi MiR-138 induces cell cycle arrest by targeting cyclin D3 in hepatocellular carcinoma Carcinogenesis 33 2012 1113 1120
14. J. Zhou, and W. Wang Analysis of microRNA expression profiling identifies microRNA-503 regulates metastatic function in hepatocellular cancer cell J. Surg. Oncol. 104 2011 278 283
15. Y. Huang, W. Guo, and H. Kan TPX2 is a prognostic marker and contributes to growth and metastasis of human hepatocellular carcinoma Int. J. Mol. Sci. 15 2014 18148 18161
16. S.L. Friedman Mechanisms of disease: mechanisms of hepatic fibrosis and therapeutic implications Nat. Clin. Pract. Gastroenterol. Hepatol. 1 2004 98 105
17. C. Li, W. Yang, J. Zhang, X. Zheng, Y. Yao, K. Tu, and Q. Liu SREBP-1 has a prognostic role and contributes to invasion and metastasis in human hepatocellular carcinoma Int. J. Mol. Sci. 15 2014 7124 7138
18. H. Xia, L.L. Ooi, and K.M. Hui MicroRNA-216a/217-induced epithelial-mesenchymal transition targets PTEN and SMAD7 to promote drug resistance and recurrence of liver cancer Hepatology 58 2013 629 641
19. A.L. Smith, R. Iwanaga, D.J. Drasin, D.S. Micalizzi, R.L. Vartuli, A.C. Tan, and H.L. Ford The miR-106b-25 cluster targets Smad7, activates TGF-beta signaling, and induces EMT and tumor initiating cell characteristics downstream of Six1 in human breast cancer Oncogene 31 2012 5162 5171
20. Z. Liu, K. Tu, and Q. Liu Effects of microRNA-30a on migration, invasion and prognosis of hepatocellular carcinoma FEBS Lett. 588 2014 3089 3097
21. P. Reichl, C. Haider, M. Grubinger, and W. Mikulits TGF-beta in epithelial to mesenchymal transition and metastasis of liver carcinoma Curr. Pharm. Des. 18 2012 4135 4147
22. H. Hayashi, S. Abdollah, Y. Qiu, J. Cai, Y.Y. Xu, B.W. Grinnell, M.A. Richardson, J.N. Topper, M.A. Gimbrone Jr., J.L. Wrana, and D. Falb The MAD-related protein Smad7 associates with the TGFbeta receptor and functions as an antagonist of TGFbeta signaling Cell 89 1997 1165 1173
23. A. Nakao, M. Afrakhte, A. Moren, T. Nakayama, J.L. Christian, R. Heuchel, S. Itoh, M. Kawabata, N.E. Heldin, C.H. Heldin, and P. ten Dijke Identification of Smad7, a TGFbeta-inducible antagonist of TGF-beta signalling Nature 389 1997 631 635
24. I. Keklikoglou, C. Koerner, C. Schmidt, J.D. Zhang, D. Heckmann, A. Shavinskaya, H. Allgayer, B. Guckel, T. Fehm, and A. Schneeweiss MicroRNA-520/373 family functions as a tumor suppressor in estrogen receptor negative breast cancer by targeting NF-kappaB and TGF-beta signaling pathways Oncogene 31 2012 4150 4163
25. S. Toffanin, Y. Hoshida, A. Lachenmayer, A. Villanueva, L. Cabellos, B. Minguez, R. Savic, S.C. Ward, S. Thung, and D.Y. Chiang MicroRNA-based classification of hepatocellular carcinoma and oncogenic role of miR-517a Gastroenterology 140 1618-1628 2011 e1616